These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 978486)

  • 1. Studies of the metabolism of 5,5-diphenylhydantoin relating principally to the stereoselectivity of the hydroxylation reactions in man and the dog.
    Butler TC; Dudley KH; Johnson D; Roberts SB
    J Pharmacol Exp Ther; 1976 Oct; 199(1):82-92. PubMed ID: 978486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
    Butler TC; Dudley KH; Mitchell GN; Johnson D
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin metabolism in mice.
    Chow SA; Fischer LJ
    Drug Metab Dispos; 1982; 10(2):156-60. PubMed ID: 6124402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for an arene-3,4-oxide as a metabolic intermediate in the meta- and para-hydroxylation of phenytoin in the dog.
    Moustafa MA; Claesen M; Adline J; Vandervorst D; Poupaert JH
    Drug Metab Dispos; 1983; 11(6):574-80. PubMed ID: 6140142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
    Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
    J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of 5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin (Dihydrodiol) and quantitative studies of phenytoin metabolism in man.
    Maguire JH; Kraus BL; Butler TC; Dudley KH
    Ther Drug Monit; 1979; 1(3):359-70. PubMed ID: 555579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
    Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH
    Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid-induced inhibition in the biotransformation of [14C] diphenylhydantoin in rat.
    Buttar HS
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):35-57. PubMed ID: 905633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New ring-hydroxylated metabolites of propranolol: species differences and stereospecific 7-hydroxylation.
    Walle T; Oatis JE; Walle UK; Knapp DR
    Drug Metab Dispos; 1982; 10(2):122-7. PubMed ID: 6124396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
    Huang JD; Hsieh CY
    Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of p-hydroxylated and dihydrodiol metabolites of phenytoin in urine by high-performance liquid chromatography.
    Szabo GK; Pylilo RJ; Davoudi H; Browne TR
    J Chromatogr; 1990 Dec; 535(1-2):279-85. PubMed ID: 2089057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies by biointeraction chromatography of binding by phenytoin metabolites to human serum albumin.
    Ohnmacht CM; Chen S; Tong Z; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 836(1-2):83-91. PubMed ID: 16621742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute configuration of (+)-5-(o-hydroxyphenyl)-5-phenylhydantoin, the major metabolite of 5,5-diphenylhydantoin in the dog.
    Maguire JH; Butler TC; Dudley KH
    J Med Chem; 1978 Dec; 21(12):1294-7. PubMed ID: 722736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary output changes in racemic ethylamphetamine and optical activity discrimination in rat urine by HPLC analysis.
    Matsushima K; Nagai T; Kanaya H; Kato Y; Takahashi M; Kamiyama S
    Nihon Hoigaku Zasshi; 1998 Feb; 52(1):19-26. PubMed ID: 9591399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4.
    Komatsu T; Yamazaki H; Asahi S; Gillam EM; Guengerich FP; Nakajima M; Yokoi T
    Drug Metab Dispos; 2000 Nov; 28(11):1361-8. PubMed ID: 11038165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
    Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereochemical aspects of the metabolism of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
    Maguire JH; Kraus BL; Butler TC; Dudley KH
    Drug Metab Dispos; 1981; 9(5):393-401. PubMed ID: 6117436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 5-(p-hydroxyphenyl)-5-phenylhydantoin and studies relating to the disposition of phenytoin in man.
    Witkin KM; Bius DL; Teague BL; Wiese LS; Boyles LW; Dudley KH
    Ther Drug Monit; 1979; 1(1):11-34. PubMed ID: 553326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5,5-Bis(3-hydroxyphenyl)hydantoin, a minor metabolite of diphenylhydantoin (dilantin) in the rat and human.
    Thompson RM; Beghin J; Fife WK; Gerber N
    Drug Metab Dispos; 1976; 4(4):349-56. PubMed ID: 8289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen-18 incorporation studies of the metabolism of phenytoin to the catechol.
    Billings RE; Fischer LJ
    Drug Metab Dispos; 1985; 13(3):312-7. PubMed ID: 2861989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.